North Carolina Genomic Evaluation by Next-generation Exome Sequencing, 2 (NCGENES2)
Sponsor: East Carolina University
A NA clinical study on Autism Spectrum Disorder and Brain Malformation, this trial is completed. The trial is conducted by East Carolina University and has accumulated 13 data snapshots since 2018. Psychiatric clinical trials are essential for establishing evidence-based treatment standards.
Status Flow
Change History
13 versions recorded-
Jun 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Sep 2024 — Jun 2025 [monthly]
Active Not Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting NA
-
Apr 2024 — Jul 2024 [monthly]
Active Not Recruiting NA
Status: Unknown Status → Active Not Recruiting
-
Jan 2024 — Apr 2024 [monthly]
Unknown Status NA
Status: Active Not Recruiting → Unknown Status
▶ Show 8 earlier versions
-
Jan 2022 — Jan 2024 [monthly]
Active Not Recruiting NA
Status: Enrolling By Invitation → Active Not Recruiting
-
Apr 2021 — Jan 2022 [monthly]
Enrolling By Invitation NA
-
Jan 2021 — Apr 2021 [monthly]
Enrolling By Invitation NA
-
Dec 2020 — Jan 2021 [monthly]
Enrolling By Invitation NA
Status: Recruiting → Enrolling By Invitation
-
Feb 2020 — Dec 2020 [monthly]
Recruiting NA
-
Nov 2019 — Feb 2020 [monthly]
Recruiting NA
-
Nov 2018 — Nov 2019 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Jul 2018 — Nov 2018 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- East Carolina University
- Mission Health System, Asheville, NC
- National Human Genome Research Institute (NHGRI)
- University of North Carolina, Chapel Hill
For direct contact, visit the study record on ClinicalTrials.gov .